Xenon Pharmaceuticals (NASDAQ:XENE) Earns Overweight Rating from Analysts at Wells Fargo & Company
Wells Fargo & Company began coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a research report report published on Wednesday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $48.00 target price on the biopharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on XENE. […]
More Stories
Fifty Shades of Grey Star, Dakota Johnson, Net Worth and Salary in 2026
The Fifty Shades of Grey lead actress is once again in the spotlight after she appeared kissing her recent boyfriend,...
CapCut Vs InShot: Which is the Best Video Editing Tool?
Videos have become one of the most useful and important tools for every marketing organization. In this digital era, more...
Louisiana Gunman Kills at Least 8 Children in Morning Shooting Spree
By Jacki Thrapp At least eight children were killed during a shooting in Shreveport, Louisiana, on the morning of April...
US to Create 4000-Acre High-Tech Economic Security Zone in the Philippines
By Guy Birchall The United States and the Philippines are set to build a 4,000-acre industrial hub after Manila became...
Trump Says US Negotiators Will Travel to Pakistan for Peace Talks With Iran
By Tom Gantert President Donald Trump said on Sunday that U.S. representatives will arrive in Pakistan on Monday evening in...
Six Dead After Shooter Opens Fire in Kyiv
By Jacki Thrapp At least six people died on April 18 when a man opened fire in Kyiv’s Holosiivskyi district....